Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 3 Pain 3 Colorectal Neoplasms 2 Supratentorial Neoplasms 1 Prostatic Neoplasms 1 Postoperative Complications 1 Pancreatic Ductal Adenocarcinoma 1 Pain, Intractable 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Meningioma 1 Lung Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Colonic Neoplasms 1 Cancer Pain 1 Breast Neoplasms 1 Benign Gynecologic Neoplasm 1 Agnosia 1 Acute Pain 1 Abdominal Neoplasms 1

Interventions

titanium silicide 1 glucoraphanin 1 Saline Solution 1 S 1 (combination) 1 Ropivacaine 1 Robotic Surgical Procedures 1 Pancreaticoduodenectomy 1 Oxaliplatin 1 Irinotecan 1 Immunotherapy 1 Conversion to Open Surgery 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Ductal Adenocarcinoma × Ropivacaine × Clear all

NCT06214533 2024-01-19

CEBOIDS

Sixth Affiliated Hospital, Sun Yat-sen University

Phase NA Unknown

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡